Pharmaceuticals, Biotechnology and Life Sciences
Celgene expects the transaction for Juno Therapeutics shares, to close in the first quarter of 2018. The company has said Wednesday…
Tetraphase Pharmaceuticals which creates antibiotics to treat life-threatening multidrug-resistant (MDR) infections, has gotten a licensing agreement with Everest Medicines Limited,…
CARB-X has announced its 2018 rounds of funding to support research into the development of antibiotics, vaccines, diagnostics, devices and…
Ritter Pharmaceuticals will seek to do make sure its first pivotal Phase 3 clinical trial of RP-G28 for lactose intolerance…
Hikma Pharmaceuticals has appointed Sigurdur (Siggi) Olafsson as Chief Executive Officer (CEO), who will also join Hikma’s Board of Directors…
Horizon Discovery’s CEO Darrin M. Disley has decided to step down to “pursue other business interests”. To replace him temporarily,…
Shire, Microsoft and EURORDIS-Rare Diseases Europe want to handle together with the diagnostic challenge for patients living with a rare…
AstraZeneca and MedImmune, its global biologics research and development arm, got clearance from the FDA to have Imfinzi for the…
Creso Pharma Limited has completed the acquisition of emerging Nova Scotia-based medicinal cannabis producer, Mernova Medicinal Inc (Mernova).
Celgene Corporation said Monday that data from the phase III Relief clinical trial of Otezla in patients with active Behçet’s…